ProCrea

What ProCrea does

Next Fertility ProCrea is a Swiss fertility clinic headquartered in Lugano, legally incorporated as Procrea Centro Fertilità Svizzera Italiana Sa, operating since 1999 and owned by the Next Fertility Group (Next Clinics) network spanning Italy, Switzerland, and Spain. The clinic provides a comprehensive range of assisted reproduction services centered on three core procedures — intrauterine insemination (IUI, €1,200), IVF/ICSI (€5,600), and egg donation (€7,600-€9,500) — supported by MicroTESE for non-obstructive azoospermia (sperm retrieval rates ~60%), oocyte and semen cryopreservation, full preimplantation genetic testing (PGT-A, PGT-SR, PGT-M, €700-€4,900), genetic matching (CGT), and non-invasive prenatal testing under the PrenatalNext sub-brand. The clinical team of 40+ professionals, including Scientific Director Dr. Giovanni M. Colpi (one of the world's leading MicroTESE specialists with 1,300+ procedures), operates from a 1,800 square meter facility housing embryology and andrology laboratories, two operating rooms, and recovery areas.

The business model is direct-to-consumer with a sales-led acquisition motion: patients book a free initial consultation (online or in-clinic), after which they pay per treatment cycle or per genetic analysis. Pricing is denominated in euros and publicly disclosed, with cryopreservation services generating recurring annual fees (€300/year from year 4 onward) on top of one-time treatment revenue. Geographic reach is regional with cross-border extension: primary catchment is Italian-speaking Switzerland (Ticino) and northern Italy (Lombardy), with a dedicated Italian phone line, and egg donation services coordinated with Next Fertility Spain and Italian partner clinics. Customer segments span infertile heterosexual couples, same-sex female couples (since 2022), women seeking social freezing, men with male-factor infertility (including azoospermia requiring MicroTESE), and oncology fertility preservation cases.

Go-to-market is multi-channel: a multilingual website (Italian, English, French, German), active social media presence on Facebook, Instagram, YouTube, and LinkedIn, patient testimonials, and educational content, complemented by a private patient portal (webportal.procrea.ch). The clinic is positioned as a premium, multidisciplinary fertility center offering complementary services such as psychotherapy, acupuncture, 3D-4D ultrasound, and menopause care under a "Centro della Salute" (Health Center) umbrella, reinforcing a patient-experience-led value proposition in a market where Swiss regulatory restrictions and clinical outcomes drive patient selection.

Name

ProCrea

Legal name

Procrea Centro Fertilità Svizzera Italiana Sa

Website

https://nextfertilityprocrea.ch

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Next Fertility ProCrea is a Swiss fertility clinic in Lugano offering IUI, IVF/ICSI, egg donation, MicroTESE, and genetic testing to infertile couples, same-sex female couples, and individuals seeking fertility preservation across Switzerland and northern Italy.

Ownership category

akta.pro rank

Product category

Fertility Clinic Services

NAICS

Family Planning Centers (62141)

akta.pro primary industry

Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)

akta.pro secondary industries

Reproductive Endocrinology & Infertility (IVF/Fertility) (HLAKAJAC), Fertility & Reproductive Endocrinology Telehealth (IVF/IUI, infertility evaluation) (HLALAHAA), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Male Reproductive & Sexual Medicine (Andrology) (HLAKAOAD)

Keywords

• Assisted reproduction treatments
• In vitro fertilization services
• Fertility preservation services
• Preimplantation genetic testing
• Male infertility treatment

Headquarters

HQ city

Lugano

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Assisted Reproduction Treatments: Revenue from fertility treatments including IUI (€1,200), IVF/ICSI (€5,600), IVF/ICSI natural cycle (€3,000), IVF/ICSI DUAL STIM (€9,400), egg donation with transfer to Italy (€7,600-€9,500 depending on blastocyst guarantee), oocyte cryopreservation, and thawing/embryo transfer (€2,000). First consultation is free.
2. Genetic Testing Services: PGT-A (€850 first blastocyst, €700 subsequent), PGT-SR (€1,100 first, €950 subsequent), PGT-M (€1,750 setup + €3,150 analysis), genetic matching/CGT, and NIPT prenatal testing.
3. Cryopreservation Services: Oocyte and sperm cryopreservation with annual renewal fees (€300/year for oocyte cryopreservation from fourth year onward).

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Next Fertility ProCrea is a Swiss fertility clinic providing assisted reproduction treatments, including intrauterine insemination (IUI), in vitro fertilization (IVF/ICSI), egg donation programs, micro-surgical sperm retrieval (MicroTESE), and oocyte/sperm cryopreservation (social freezing). The clinic complements these procedures with preimplantation genetic testing (PGT-A, PGT-SR, PGT-M), carrier genetic matching, NIPT prenatal screening, 3D-4D ultrasound diagnostics, psychotherapeutic support, and acupuncture, delivered from a 1,800 sqm facility in Lugano with on-site embryology and andrology laboratories.

Product overview

Next Fertility ProCrea is a Swiss fertility clinic offering a comprehensive range of assisted reproduction treatments centered around three core procedures: Intrauterine Insemination (IUI), In Vitro Fertilization (IVF/ICSI), and Egg Donation. The clinic provides complementary services including fertility preservation (oocyte and semen cryopreservation), advanced genetic testing (PGT-A, PGT-SR, PGT-M), genetic matching, and NIPT prenatal testing. Support services include genetic counseling, psychotherapeutic support, acupuncture, and 3D-4D ultrasound diagnostics. The facility features embryology and andrology laboratories, two operating rooms, and a private patient portal (webportal.procrea.ch) for managing patient information. Located in Lugano since 1999, the clinic is part of the Next Fertility Group network.

Differentiator

Problem solved

Functional benefit

Brands

• PrenatalNext: Non-invasive prenatal testing (NIPT) service for chromosomal abnormality screening during pregnancy.
• PrenatalNext (NIPT)

Products and services

• Intrauterine Insemination (IUI)

Quantifiable outcome

• Approximately 90% oocyte survival rate after vitrification and thawing
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Next Fertility Group / Next ClinicscoreStrategic or Co-development PartnerNext Fertility ProCrea is part of the Next Clinics / Next Fertility international group of fertility centers. The group provides shared standards, protocols, and best practices across its network of clinics, enabling access to international expertise and coordinated research.
• Next Fertility SpaincoreStrategic or Co-development PartnerEgg donation services are provided through collaboration with Next Fertility Spain, where donors are recruited and blastocysts are created. This partnership enables guaranteed blastocyst outcomes (1 or 2) for egg donation treatments, with embryo transfer performed at Italian collaboration centers.
• Centro Medico Le Betulle (Appiano Gentile, Como - Italy)coreChannel Partner/ Reseller/ DistributorItalian collaboration center where embryo transfers are performed for egg donation treatments. Part of the cross-border treatment program where egg donation occurs in Spain and embryo transfer is performed in Italy.
• Rete Donna Svizzera (Swiss Women's Network)minorGTM or Marketing PartnerNext Fertility ProCrea supports Rete Donna Svizzera, a women's health network, demonstrating commitment to women's health awareness and community engagement.

Scale indicators4 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• CCRM (Colorado Center for Reproductive Medicine):
• CARE Fertility: UK-headquartered fertility clinic group offering IVF, ICSI, egg donation, and PGT across multiple UK sites. Comparable in service breadth (full reproductive medicine), cross-border patient ambitions, and clinical technology stack.
• IVI RMA Global: One of the world's largest fertility clinic networks (IVI + RMA merger), with major presence across Spain and Europe. Directly comparable to ProCrea as a multi-country IVF/IUI/egg donation provider with cross-border patient programs — a much larger scale competitor in the same addressable market.

Direct peers

• Next Fertility Italia (Next Fertility Milano): Sister clinic within the Next Fertility Group network, located in Milan. Operates the same IVF/ICSI, egg donation, and PGT service portfolio targeting Italian patients. Most directly comparable peer given shared brand, protocols, and patient acquisition overlap.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@ProcreaCh
• Facebookfacebook.com/ProCrea.ch
• LinkedInlinkedin.com/company/nextfertility-italy
• Instagraminstagram.com/nextfertilityprocrea

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ProCrea